Targeting therapeutic agent against C3b/C4b, SB002, on the inflammation-induced bone loss in experimental periodontitis.

Ren-Yeong HuangFang-Yi TsengJhong-Jhe YouThomas E Van DykeChia-Dan ChengCheng-En SungPei-Wei WengYi-Shing ShiehWan-Chien Cheng

Published in: Journal of clinical periodontology (2023)

The association between C3b/C4b and periodontitis may provide a basis for the development of novel therapeutic strategies for periodontitis and other inflammatory diseases.

Keyphrases

bone loss
oxidative stress
diabetic rats
high glucose
cancer therapy
endothelial cells